SEC Form 4 · accession 0001144204-15-012192
KIORA PHARMACEUTICALS INC · KPRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Praveen Tyle
Director
Period of report
Feb 24, 2015
Accepted (ET)
Feb 26, 2015 · 2:50 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001372514
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $5.75 | Feb 24, 2015 | A | 20,000 | A | — | Feb 24, 2025 | Common Stock | 20,000 | 20,000 | D |
Explanation of responses
- F125% of the option shares vested and became exercisable as of the Transaction Date, 25% of the option shares vest and become exercisable on February 24, 2016, and the remaining option shares vest and become exercisable in 24 consecutive equal monthly installments on the first calendar day of each month thereafter.
Remarks
*Signed under power of attorney on behalf of Reporting Person